Advertisement
AORT vs MYGN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a StrongBuy and MYGN is a Hold.
AORT's Stochastic Oscillator is sitting in oversold zone for 3 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +12.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in 221 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
AORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day RSI Indicator for AORT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 23 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AORT as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for AORT turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 35 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
AORT moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AORT crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for AORT entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.211) is normal, around the industry mean (4.142). AORT's P/E Ratio (-404.200) is considerably lower than the industry average of (3.291). Projected Growth (PEG Ratio) (4.200) is also within normal values, averaging (11.253). Dividend Yield (0.006) settles around the average of (0.011) among similar stocks. P/S Ratio (2.603) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. AORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for MYGN turns negative, indicating new downward trend
MYGN saw its Momentum Indicator move below the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 78 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for MYGN moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Moving Average Convergence Divergence Histogram (MACD) for MYGN turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 35 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
MYGN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for MYGN moved above the 200-day moving average on November 11, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +6.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYGN advanced for three days, in 201 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 102 of 160 cases where MYGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. MYGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.863) is normal, around the industry mean (67.298). P/E Ratio (-5.017) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.236) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (0.448) is also within normal values, averaging (9.775).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
AORT | MYGN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 61 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 97 | |
PRICE GROWTH RATING 1..100 | 78 | 35 | |
P/E GROWTH RATING 1..100 | 99 | 45 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AORT's Valuation (3) in the Medical Specialties industry is somewhat better than the same rating for MYGN (61) in the Biotechnology industry. This means that AORT’s stock grew somewhat faster than MYGN’s over the last 12 months.
AORT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MYGN (100) in the Biotechnology industry. This means that AORT’s stock grew similarly to MYGN’s over the last 12 months.
AORT's SMR Rating (91) in the Medical Specialties industry is in the same range as MYGN (97) in the Biotechnology industry. This means that AORT’s stock grew similarly to MYGN’s over the last 12 months.
MYGN's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for AORT (78) in the Medical Specialties industry. This means that MYGN’s stock grew somewhat faster than AORT’s over the last 12 months.
MYGN's P/E Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for AORT (99) in the Medical Specialties industry. This means that MYGN’s stock grew somewhat faster than AORT’s over the last 12 months.
| AORT | MYGN | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 74% | 3 days ago 85% |
| Stochastic ODDS (%) | 3 days ago 77% | 3 days ago 71% |
| Momentum ODDS (%) | 3 days ago 61% | 3 days ago 90% |
| MACD ODDS (%) | 3 days ago 73% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 68% | 3 days ago 86% |
| TrendMonth ODDS (%) | 3 days ago 70% | 3 days ago 74% |
| Advances ODDS (%) | 12 days ago 73% | 18 days ago 72% |
| Declines ODDS (%) | 3 days ago 67% | 3 days ago 84% |
| BollingerBands ODDS (%) | 3 days ago 69% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 69% | 3 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AORT’s FA Score shows that 1 FA rating(s) are green while MYGN’s FA Score has 0 green FA rating(s).
- AORT’s FA Score: 1 green, 4 red.
- MYGN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AORT’s TA Score shows that 3 TA indicator(s) are bullish while MYGN’s TA Score has 4 bullish TA indicator(s).
- AORT’s TA Score: 3 bullish, 7 bearish.
- MYGN’s TA Score: 4 bullish, 5 bearish.
Price Growth
AORT (@Medical/Nursing Services) experienced а -5.49% price change this week, while MYGN (@Medical Specialties) price change was -4.39% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.79%. For the same industry, the average monthly price growth was -7.29%, and the average quarterly price growth was +34.42%.
Reported Earning Dates
AORT is expected to report earnings on Feb 18, 2027.
MYGN is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Medical/Nursing Services (+1.37% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-1.79% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
AORT and
Correlation & Price change
A.I.dvisor indicates that over the last year, AORT has been loosely correlated with GMED. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then GMED could also see price increases.
| Ticker / NAME | Correlation To AORT | 1D Price Change % | ||
|---|---|---|---|---|
| AORT | 100% | -1.55% | ||
| GMED - AORT | 57% Loosely correlated | -0.22% | ||
| VREX - AORT | 55% Loosely correlated | -0.93% | ||
| TCMD - AORT | 43% Loosely correlated | -0.04% | ||
| LMAT - AORT | 42% Loosely correlated | +0.82% | ||
| MDT - AORT | 41% Loosely correlated | +1.85% | ||
More | ||||
MYGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with FLGT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then FLGT could also see price increases.
| Ticker / NAME | Correlation To MYGN | 1D Price Change % | ||
|---|---|---|---|---|
| MYGN | 100% | -0.35% | ||
| FLGT - MYGN | 38% Loosely correlated | -0.76% | ||
| ADPT - MYGN | 38% Loosely correlated | -1.49% | ||
| NEO - MYGN | 37% Loosely correlated | -3.14% | ||
| ATEC - MYGN | 34% Loosely correlated | +0.14% | ||
| AORT - MYGN | 31% Poorly correlated | -1.55% | ||
More | ||||